AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25139116
Drug: Adjunctive systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive systemic amoxicillin and metronidazole (AMX-MET) during non-surgical treatment
Trial: 25139116
Drug: Adjunctive systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive systemic amoxicillin and metronidazole (AMX-MET)
Trial: 27607363
Drug: Low-dose tacrolimus
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose tacrolimus
Trial: 15216449
Drug: Moxonidine (MOX)
DrugBank: Moxonidine (DB09242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxonidine (MOX) 0.2 - 0.6 mg/d
Trial: 15216449
Drug: Metoprolol (MET)
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol (MET) 50 - 150 mg/d
Trial: 137921
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide via metered-dose inhaler
Trial: 21341919
Drug: Galantamine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (8 mg/day)
Trial: 28876367
Drug: Xuezhikang (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuezhikang (1200 mg/day, orally)
Trial: 11228592
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (plain and enteric-coated formulations)
Trial: 3055941
Drug: Plain aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain aspirin
Trial: 11228592
Drug: First two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First two months of treatment with low-dose aspirin
Trial: 9334096
Drug: Intragastric balloon
RxNorm normalized name: CATHETER,BALLOON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intragastric balloon implantation with intensive additional therapy by a dietitian (Group II)
Trial: 9334096
Drug: Sham implantation
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham implantation with intensive additional therapy by a dietitian (Group III)
Trial: 8487488
Drug: Theophylline 10
RxNorm normalized name: theophylline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline 10 mg/kg and 20 mg/kg body weight
Trial: 3326114
Drug: Zopiclone 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 5.0 mg
Trial: 3326114
Drug: Zopiclone 10.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zopiclone 10.0 mg
Trial: 31465720
Drug: Melatonin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (6 mg)
Trial: 26604649
Drug: Entecavir (ETV)
RxNorm normalized name: Entecavir
DrugBank: Entecavir (DB00442)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Entecavir (ETV) therapy
Trial: 21199833
Drug: Satavaptan 25
RxNorm normalized name: Satavaptan
DrugBank: Satavaptan (DB14923)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satavaptan 25 mg/day
Trial: 21199833
Drug: Satavaptan 50
RxNorm normalized name: Satavaptan
DrugBank: Satavaptan (DB14923)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satavaptan 50 mg/day in CHF patients
Trial: 21199833
Drug: Satavaptan therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Satavaptan therapy
Trial: 17135984
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (FLX and CBT)
Trial: 17603143
Drug: Daily step
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daily step count equating to 1-hr MVPA engagement
Trial: 16089149
Drug: Angong niuhuang
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angong niuhuang pill (ANP)
Trial: 7801868
Drug: Hirudin (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin (dose 3: 0.6 mg/kg bolus + 0.2 mg/kg/hour infusion)
Trial: 7801868
Drug: Heparin (5,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (5,000 U bolus + 1,000 U/hour infusion)
Trial: 7801868
Drug: Hirudin (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin (dose 1)
Trial: 7801868
Drug: Hirudin (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin (dose 2)
Trial: 7801868
Drug: Hirudin (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hirudin (dose 3)
Trial: 2182703
Drug: Géméprost (vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Géméprost (vaginal suppository)
Trial: 2182703
Drug: Sulprostone (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulprostone (intravenous infusion)
Trial: 6154345
Drug: Radiotherapy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy combined with chemotherapy (bleomycin)
Trial: 31974133
Drug: H. pylori
RxNorm normalized name: H. PYLORI AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H. pylori eradication therapy (295 patients)
Trial: 11912355
Drug: Brimonidine twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brimonidine twice daily
Trial: 9767193
Drug: Early antiplatelet
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early antiplatelet therapy
Trial: 11351768
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aspirin and dipyridamole
Trial: 9767193
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of antiplatelet agents (e.g. aspirin and clopidogrel)
Trial: 1995788
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered deuterated pyridoxine (PN)
Trial: 1995788
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered deuterated pyridoxine-5'-beta-D-glucoside (PN-glucoside)
Trial: 1995788
Drug: Intravenously administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenously administered pyridoxine-5'-beta-D-glucoside (PN-glucoside)
Trial: 30642737
Drug: Selenium (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium (200 μg/day)
Trial: 30700347
Drug: Chlorquinaldol‐promestriene vaginal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorquinaldol‐promestriene vaginal tablets
Trial: 30700347
Drug: Opin suppositories
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opin suppositories
Trial: 24625322
Drug: PegIFNα (type
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PegIFNα (type Y peginterferon α‐2b 90 μg, 135 μg, 180 μg and PegIFNα‐2a 180 μg, respectively, once a week) and ribavirin (< 75 kg, 1000 mg daily and ≥ 75 kg, 1200 mg daily) for 48 weeks
Trial: 22388710
Drug: Corticosteroids plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids plus pentoxifylline (prednisolone 40 mg/day plus pentoxifylline 400 mg thrice/day)
Trial: 22388710
Drug: Corticosteroids alone
RxNorm normalized name: abiraterone and corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids alone (prednisolone 40 mg/day)
Trial: 11060935
Drug: Exposure with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure with counterconditioning (CC)
Trial: 3718170
Drug: Neuroleptic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic treatment (double-blind placebo-controlled)
Trial: 23946318
Drug: eletriptan 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eletriptan 80 mg (ELE-80)
Trial: 21903737
Drug: Aclidinium 400
RxNorm normalized name: aclidinium 400 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aclidinium 400 μg bid
Trial: 21903737
Drug: Tiotropium 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 8 μg once daily
Trial: 1988514
Drug: Cefotaxime, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime, 2 g intravenously every 8 h (n = 16)
Trial: 1988514
Drug: Ceftriaxone, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone, 2 g intravenously every 24 h (n = 17)
Trial: 30856079
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (4000 IU daily for 2 months)
Trial: 11144998
Drug: Tilidine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine (1.5 mg/kg) administered on the day of dialysis
Trial: 11144998
Drug: Tilidine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilidine (1.5 mg/kg) administered on a day in the dialysis-free interval
Trial: 9694404
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oral melatonin administered at 12.30 hr
Trial: 24521776
Drug: Rosuvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (20 mg/d)
Trial: 10971307
Drug: Asimadoline 10
RxNorm normalized name: Asimadoline
DrugBank: Asimadoline (DB05104)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asimadoline 10 mg
Trial: 6812685
Drug: Aspirin 40
RxNorm normalized name: aspirin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 40 mg every 48 hours
Trial: 21550310
Drug: Chloroquine phosphate
RxNorm normalized name: Chloroquine Phosphate
DrugBank: Chloroquine (DB00608)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chloroquine phosphate (500 mg/day for 1 week, then once a week to complete 12 weeks)
Trial: 30496510
Drug: Pulsed Ultrasound
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed Ultrasound (PUS) treatment
Trial: 27918196
Drug: Oral riboflavin
RxNorm normalized name: riboflavin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral riboflavin incorporated into active treatment pills
Trial: 19238488
Drug: Varenicline with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline with behavioral smoking cessation treatment
Trial: 17445101
Drug: Early Treatment
RxNorm normalized name: Clearly It!
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early Treatment (ET) with almotriptan 12.5 mg, treated at earliest onset of headache pain (within 1 hour)
Trial: 17445101
Drug: Standard Treatment
RxNorm normalized name: Azo-Standard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard Treatment (ST) with almotriptan 12.5 mg, treated when headache pain intensity is moderate or severe
Trial: 17445101
Drug: Early Treatment
RxNorm normalized name: Clearly It!
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early Treatment (ET) subgroup treating headache pain within 1 hour of onset
Trial: 17445101
Drug: Standard Treatment
RxNorm normalized name: Azo-Standard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard Treatment (ST) subgroups treating within 1 hour versus greater than 1 hour after headache onset
Trial: 17445101
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events in Early Treatment (ET) group
Trial: 17445101
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events in Standard Treatment (ST) group
Trial: 8087439
Drug: Lung Cancer
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lung Cancer Symptom Scale (LCSS) administered at baseline, day 29, and day 71
Trial: 2767747
Drug: Intrathecal pentazocine
RxNorm normalized name: Pentazocine
DrugBank: Pentazocine (DB00652)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrathecal pentazocine (0, 1, 2, 3, 4, and 5 mg) along with 1% bupivacaine
Trial: 20442758
Drug: 5 days
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 days on/2 days off treatment
Trial: 12034036
Drug: Intermediate-dose interferon-alpha2b
RxNorm normalized name: Fibroblast interferon
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermediate-dose interferon-alpha2b
Trial: 12034036
Drug: Low-dose and
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose and intermediate-dose interferon-alpha2b
Trial: 16467232
Drug: Low-fat dietary
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat dietary pattern intervention (tumor hormone receptor characteristics)
Trial: 11005044
Drug: High dosage
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dosage right unilateral ECT
Trial: 11005044
Drug: Low dosage
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dosage right unilateral ECT
Trial: 3528889
Drug: Piracetam (2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam (2.4 to 9.9 g/day)
Trial: 24194899
Drug: Sodium hypochlorite
RxNorm normalized name: Sodium hypochlorite
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium hypochlorite (liquid bleach) for household water treatment
Trial: 24194899
Drug: No water
RxNorm normalized name: ALCOHOL 70 mL in 100 mL TOPICAL GEL [70% alcohol hand sanitizer (no water)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No water treatment (Control)
Trial: 3542451
Drug: Intraperitoneal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal insulin above transverse mesocolon (0.2 IU/kg)
Trial: 3542451
Drug: Intraperitoneal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraperitoneal insulin below transverse mesocolon (0.2 IU/kg)
Trial: 3542451
Drug: Intramuscular insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular insulin (0.2 IU/kg)
Trial: 3542451
Drug: Subcutaneous insulin
RxNorm normalized name: subcutaneous insulin pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous insulin (0.2 IU/kg)
Trial: 20645484
Drug: Spinal-intravenous anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal-intravenous anesthesia and analgesia
Trial: 20645484
Drug: General-intravenous anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General-intravenous anesthesia and analgesia
Trial: 11099374
Drug: CHO +
RxNorm normalized name: G-CSF (CHO cell derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO + Cr+3 (CHO plus chromium picolinate 400 mg)
Trial: 8297447
Drug: naloxone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naloxone (2 x 0.1 mg)
Trial: 26874885
Drug: Eribulin (1·4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eribulin (1·4 mg/m² intravenously on days 1 and 8)
Trial: 26874885
Drug: Dacarbazine (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dacarbazine (850 mg/m², 1000 mg/m², or 1200 mg/m² intravenously on day 1)
Trial: 12795749
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg b.i.d
Trial: 1650106
Drug: Antidepressants (desipramine/petytyl)
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (desipramine/petytyl) and incazane
Trial: 23374372
Drug: Diet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet therapy alone (n = 25)
Trial: 21225293
Drug: 0.06 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.06 mg/kg rocuronium
Trial: 17228345
Drug: Milk (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk (1.5 l/day)
Trial: 14732826
Drug: Adherence to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adherence to hemodialysis guidelines and modifiable practices (dialysis dose, phosphate control, improved anemia, partial correction of serum albumin, reduced interdialytic weight gain, less use of catheters for vascular access)
Trial: 14732826
Drug: Having albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Having albumin <3.5 g/dl
Trial: 9842820
Drug: Prophylactic metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic metoprolol (maximal dose of 10 mg)
Trial: 7488278
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg cM-T412
Trial: 7488278
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg cM-T412
Trial: 8128188
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg cM-T412
Trial: 2570001
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg acrivastine three times daily
Trial: 25985245
Drug: EUS-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EUS-guided therapy with adalimumab (ADA)
Trial: 21214940
Drug: IPTc (monthly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IPTc (monthly IPTc with a single dose of sulphadoxine/pyrimethamine (SP) plus three doses of amodiaquine (AQ))
Trial: 16478746
Drug: Weekly darbepoetin
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly darbepoetin alfa (2.25-microg/kg)
Trial: 8260564
Drug: Intravenous adrenaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous adrenaline infusions
Trial: 3518773
Drug: Hydrochlorothiazide 50
RxNorm normalized name: hydrochlorothiazide 50 MG
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 50 mg once daily + Indomethacin 50 mg twice daily
Trial: 29469206
Drug: Sacubitril-valsartan treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sacubitril-valsartan treatment for 3 months
Trial: 27591767
Drug: reduced-dose/IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: reduced-dose/IR
Trial: 27591767
Drug: standard-dose/FBP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: standard-dose/FBP
Trial: 8821311
Drug: Daily lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily lithium dosing (700 mg)
Trial: 8821311
Drug: Alternate-day lithium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate-day lithium dosing (1200 mg)
Trial: 8002850
Drug: Cholesterol reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol reduction treatment
Trial: 3937665
Drug: Levonorgestrel contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel contraceptive implants (NORPLANT)
Trial: 31219771
Drug: Nonselective β-adrenergic
RxNorm normalized name: alpha tocopherol / ascorbic acid / cholecalciferol / docosahexaenoic acid / docusate sodium / ferrous fumarate / folic acid / pyridoxine hydrochloride / tricalcium phosphate Oral Capsule [Nexa Select]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonselective β-adrenergic blockade (40 mg propranolol)
Trial: 23547209
Drug: Belimumab 4
RxNorm normalized name: belimumab 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belimumab 4 mg/kg
Trial: 23547209
Drug: Belimumab (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belimumab (any dose) in open-label extension
Trial: 23547209
Drug: Placebo switched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo switched to belimumab 10 mg/kg in extension
Trial: 21470404
Drug: K-1 mmol/l
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K-1 mmol/l
Trial: 19817753
Drug: Oral corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral corticosteroids + Vitamin D(3)
Trial: 14872179
Drug: One injection
RxNorm normalized name: naloxone Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One injection of varicella vaccine
Trial: 14872179
Drug: Two injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two injections of varicella vaccine
Trial: 11434826
Drug: 90 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg/kg per day for 5 days (n = 398)
Trial: 11434826
Drug: 40 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/kg per day for 10 days (n = 397)
Trial: 3063288
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HCTZ with amiloride (Group 2)
Trial: 25552906
Drug: Selexipag (400-1,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selexipag (400-1,600 μg, administered twice daily for 21 days)
Trial: 25552906
Drug: Moxifloxacin (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (single oral 400 mg dose on day 2 or 24)
Trial: 15496220
Drug: Donepezil HCl
RxNorm normalized name: donepezil HCl
DrugBank: Donepezil (DB00843)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Donepezil HCl 5 mg once daily for 15 days
Trial: 15496220
Drug: Sertraline HCl
RxNorm normalized name: sertraline HCl
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline HCl 50 mg once daily for 5 days followed by 100 mg once daily for 10 days
Trial: 15496220
Drug: Concurrent administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent administration of donepezil HCl and sertraline HCl
Trial: 15496220
Drug: Sertraline HCl
RxNorm normalized name: sertraline HCl
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline HCl only